Emma Long is a chemical biologist with a background in post-translational modifications and their roles in cancer biology.
Prior to joining Jones Day in 2026, Emma received a Ph.D. from the University of Southern California, where she studied O-linked glycosylation (the attachment of carbohydrates to proteins), utilizing carbohydrate chemistry to synthesize metabolic analogues used to visualize, identify, and manipulate glycosylation in vitro. She also completed a post-doctoral fellowship at Bristol Myers Squibb, where she used heterobifunctional molecules to study oncogenic proteins through modulation of phosphorylation and ubiquitination. She has coauthored several peer-reviewed publications, including a book chapter on glycosylation.
- University of Southern California (Ph.D. in Chemistry 2021); Rhodes College (B.S. in Chemistry cum laude 2016)
- Registered to practice before the United States Patent and Trademark Office
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice